semaglutide and gastric bypass Rise of Semaglutide: Novo Nordisk, Bariatric Surgery vs Junk Food With rising interest in non-surgical

Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...

Learn more about advanced weight loss with Semaglutide and Tirzepatide, two groundbreaking, yet safe, medications offering significant results in helping patients achieve and maintain their weight loss goals.

Restore volume after GLP-1 weight loss with Sculptra at Enfuse Medical Spas in Chicagogentle, long-lasting collagen stimulation for facial rejuvenation.

You may feel full after just a few bites, experience nausea, or struggle to eat enough protein throughout the day

Glucagon linked to energy use and fat breakdown

Industry forecasts suggest that the Indian GLP-1 market could reach nearly USD 350 million (~2,900 crore) by 2030, growing at an estimated ~25% CAGR